NNC0142-0002

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0142-0002, covering 2013-10-21 to 2014-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA) [Phase 2]